Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies.
Saudi Pharm J
; 29(1): 12-26, 2021 Jan.
Article
in En
| MEDLINE
| ID: mdl-33603536
BCSCs, Breast cancer stem cells; Bioinformatics; Breast cancer stem cells; CSC, Cancer stem cell; DAVID, Database for Annotation, Visualization, and Integrated Discovery; DTPs, Direct target proteins; DXR, Doxorubicin; EGF, Epidermal growth factor; EMT, Epithelial to mesenchymal transition; ERα; FITC, fluorescein isothiocyanate; GO, Gene ontology; ITPs, Indirect target proteins; KEGG, Kyoto Encyclopedia of Genes and Genomes; MET, Metformin; MFP, Mammosphere forming potential; NAR, Naringenin; NMPs, Naringenin-mediated proteins; Naringenin; P53; PE, phycoerythrin; PPI, Protein-protein interaction; PTTN, Potential target of naringenin in inhibition of BCSCs; ROS, Reactive oxygen species; Targeted therapy; q-RT PCR, Quantitative real-time polymerase chain reaction
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Saudi Pharm J
Year:
2021
Type:
Article
Affiliation country:
Indonesia